🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess whether co-administration of belimum...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-03-01
Trial ID
NCT03312907
The purpose of this study is to evaluate the efficacy and safety of belimum...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-05-23
Trial ID
NCT01345253
Even though glucocorticoid is the current first line medication for IgG4-RD...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2021-01
Trial ID
NCT04660565
Treatments Being Tested
Background: People with Idiopathic CD4 lymphopenia (ICL) have lower number...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2020-01-13
Trial ID
NCT04097561
Treatments Being Tested
Mechanistic study to assess whether dual B-cell immunotherapy by co-adminis...
Status
Unknown
Location
Addenbrooke's Hospital
Start Date
2019-02-01
Trial ID
NCT03967925
Treatments Being Tested
The purpose of this study is to test the safety and tolerability of repeate...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2008-10
Trial ID
NCT00732940
Treatments Being Tested
To investigate the efficacy of belimumab in early SLE patients (disease dur...
Status
Completed
Location
Peking Union Medical College hospital
Start Date
2021-09-01
Trial ID
NCT04956484
Treatments Being Tested
Neuromyelitis Optica Spectrum Disorders (NMOSD) is associated with a pathol...
Status
Completed
Location
Tianjin Medical University General Hospital
Start Date
2021-12-12
Trial ID
NCT05154734
Treatments Being Tested
Systemic lupus erythematosus is a chronic autoimmune disease, which can inv...
Status
Unknown
Location
Multiple Locations
Start Date
2023-06-01
Trial ID
NCT05585671
Treatments Being Tested
GlaxoSmithKline (GSK) have submitted a Biologic License Application (BLA) f...
Status
No Longer Available
Location
GSK Investigational Site
Start Date
TBD
Trial ID
NCT03125486
Treatments Being Tested